These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7235996)
1. Evaluating the mutagenic potential of chemicals. The minimal battery and extrapolation problems. Sobels FH Arch Toxicol; 1980 Nov; 46(1-2):21-30. PubMed ID: 7235996 [No Abstract] [Full Text] [Related]
2. The place of the host-mediated assay. McGregor DB Arch Toxicol; 1980 Nov; 46(1-2):111-21. PubMed ID: 7235988 [No Abstract] [Full Text] [Related]
3. Appreciation of the value of different bacterial test systems for detecting and for ranking chemical mutagens. Mohn GR; Ellenberger J Arch Toxicol; 1980 Nov; 46(1-2):45-60. PubMed ID: 7235998 [No Abstract] [Full Text] [Related]
4. [Potential use of bacterial mutagenic tests for screening chemical carcinogens]. Khudoleĭ VV Vopr Onkol; 1982; 28(7):80-6. PubMed ID: 7048737 [No Abstract] [Full Text] [Related]
5. Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay. Morimoto I; Watanabe F; Osawa T; Okitsu T; Kada T Mutat Res; 1982 Apr; 97(2):81-102. PubMed ID: 6804865 [TBL] [Abstract][Full Text] [Related]
6. Mutagenicity testing with eukaryotic microorganisms. Moustacchi E Arch Toxicol; 1980 Nov; 46(1-2):99-110. PubMed ID: 7016074 [TBL] [Abstract][Full Text] [Related]
7. A proposed battery of tests for the initial evaluation of the mutagenic potential of medicinal and industrial chemicals. Ishidate M Mutat Res; 1988; 205(1-4):397-407. PubMed ID: 3367924 [No Abstract] [Full Text] [Related]
9. The use of marine bacteria in mutagenicity assays. Podgórska B; Wegrzyn G Pol J Microbiol; 2007; 56(4):227-31. PubMed ID: 18254491 [TBL] [Abstract][Full Text] [Related]
10. Assembling a battery of assays to predict carcinogenicity: a case study. Rosenkranz HS; Pet-Edwards J; Chankong V; Haimes YY Mutat Res; 1984 Sep; 141(1):65-8. PubMed ID: 6482896 [No Abstract] [Full Text] [Related]
14. [Carcinogen screening in mammalian cells in vitro. The clastogenicity and the SCE test]. Thust R Zentralbl Allg Pathol; 1984; 129(4):365-70. PubMed ID: 6395564 [TBL] [Abstract][Full Text] [Related]
15. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens. Styles JA; Penman MG Mutat Res; 1985 Nov; 154(3):183-204. PubMed ID: 3900714 [TBL] [Abstract][Full Text] [Related]
16. Use of the Miniscreen assay to screen novel compounds for bacterial mutagenicity in the pharmaceutical industry. Burke DA; Wedd DJ; Burlinson B Mutagenesis; 1996 Mar; 11(2):201-5. PubMed ID: 8671739 [TBL] [Abstract][Full Text] [Related]
17. Long-term and short-term screening assays for carcinogens: a critical appraisal. IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):1-426. PubMed ID: 6935176 [No Abstract] [Full Text] [Related]
18. Bacterial-mammalian mutagenesis correlations: mechanistic significance for carcinogenesis. Bartsch H Ann N Y Acad Sci; 1983; 407():351-61. PubMed ID: 6576679 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for the testing of chemical for mutagenicity. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment. Rep Health Soc Subj (Lond); 1981; 24():1-95. PubMed ID: 7244358 [No Abstract] [Full Text] [Related]
20. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group. Morita T; Asano N; Awogi T; Sasaki YF; Sato S; Shimada H; Sutou S; Suzuki T; Wakata A; Sofuni T; Hayashi M Mutat Res; 1997 Feb; 389(1):3-122. PubMed ID: 9062586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]